Dentsply International
CompanyUnited StatesFounded 1899
Dentsply International develops one asset, approved (lidocaine and prilocaine in anesthesia). Mostly small molecule; based in the United States, founded in 1899.
- 1
- Asset
- Furthest stage
- Approved
- 1
- Trial
- 0
- Signals
Pipeline
1Blocks voltage-gated sodium channels to provide local anesthesia during periodontal treatment.
Approved, Small molecule, anesthesia, periodontal disease (Phase 3)
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Similar companies6